Monarch Partners Asset Management LLC Harvard Bioscience Inc Transaction History
Monarch Partners Asset Management LLC
- $328 Million
- Q4 2022
A detailed history of Monarch Partners Asset Management LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 613,837 shares of HBIO stock, worth $1.33 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
613,837
Previous 801,259
23.39%
Holding current value
$1.33 Million
Previous $2.05 Million
17.11%
% of portfolio
0.52%
Previous 0.62%
Shares
8 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
31.5MCall Options Held
700Put Options Held
2.1K-
Black Rock Inc. New York, NY2.84MShares$6.17 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$6.02 Million0.44% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.72MShares$5.89 Million0.87% of portfolio
-
Amh Equity LTD2.39MShares$5.18 Million8.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$4.67 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $90.4M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...